Home › Funds › Palo Alto Investors LP › UTHR

Palo Alto Investors LP position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

Palo Alto Investors LP reported holding 58,875 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$31.9M, representing 4.75% of its reported portfolio and ranking #7 among its reported holdings. Palo Alto Investors LP has disclosed UTHR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)58.88K sh
Reported value held$31.90M
Portfolio Weight4.75%
First reportedQ3 2023
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Palo Alto Investors LP's UTHR position evolved

Palo Alto Investors LP first disclosed a stake in UTHR in Q3 2023 at 575,907 shares (US$130.1M). Across 13 filings, Palo Alto Investors LP increased the stake 1 time(s), trimmed it 8 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 58,875 shares valued at US$31.9M — a reduction of -3,712 shares quarter over quarter.. Notable position changes include a 32% trim in Q1 2024 (shares rose 39% over the following quarter), a 32% trim in Q1 2025 (shares fell 8% over the following quarter), a 39% trim in Q3 2025 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 575.91K $130.08M New
Q4 2023 395.78K $87.03M Reduce
Q1 2024 267.76K $61.51M Reduce
Q2 2024 266.91K $85.03M Hold
Q3 2024 183.25K $65.67M Reduce
Q4 2024 155.71K $54.94M Reduce
Q1 2025 105.23K $32.44M Reduce
Q2 2025 95.48K $27.44M Reduce
Q3 2025 58.19K $24.39M Reduce
Q4 2025 58.19K $28.35M Hold
Q1 2026 62.81K $37.24M Add
Q2 2026 62.59K $33.91M Hold
Q3 2026 58.88K $31.90M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 38 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.49B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has Palo Alto Investors LP held UTHR?

Palo Alto Investors LP has disclosed UTHR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Palo Alto Investors LP's current position in UTHR?

As of Q3 2026, Palo Alto Investors LP holds 58.88K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $31.90M, representing 4.75% of its reported portfolio and ranking #7.

Has Palo Alto Investors LP been buying or selling UTHR?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP reduced its position in UTHR.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.